FDA Inspection 1228558 — Claire A. Booth, MBBS PhD
The FDA completed an inspection of Claire A. Booth, MBBS PhD on Jan 17, 2024 in London. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 17, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- London (United Kingdom)
Additional Details
Clinical Investigator (CI)